Intelligent Bio Solutions Inc.
IBS Inc. has signed a distribution agreement for its Intelligent Fingerprinting Drug Screening System with Chile-based company TSCOM SPA, increasing
IBS Inc. has received guidance from the U.S. Food and Drug Administration regarding the regulatory classification of its Intelligent Fingerprinting
Intelligent Bio Solutions has received a second progress payment of USD $1.43 million as part of a scientific grant awarded
Intelligent Bio Solutions has announced that management will be participating in the LD Micro Invitational XIII in Los Angeles, June
Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs.
Intelligent Bio Solutions Inc. today announced its financial results for its fiscal third quarter ended March 31, 2023, and provided
Intelligent Bio Solutions Inc. announces the recruitment of four highly experienced sales executives from across the workplace safety and supply,
Dodman Limited, specialists in the design, manufacture, installation and maintenance of processing systems for major food manufacturers, has selected our
Intelligent Bio Solutions has been granted a patent in the United Kingdom (UK) relating to its Intelligent Fingerprinting Drug Screening
A & F Sprinklers, one of the UK’s leading fire protection and automatic sprinkler systems specialists, has selected Intelligent Bio
Intelligent Bio Solutions has selected Human and Supplement Testing Australia (“HASTA”), Australia’s largest independent sports drug testing laboratory, as its
Intelligent Bio Solutions today announced the closing of its previously announced underwritten public offering. Ladenburg Thalmann & Co. Inc. acted
NEW YORK, NY, March 8, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a
NEW YORK, NY, March 07, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a
NEW YORK, NY, March 1, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a
